Monitoring of 5% Treatment Naïve Intravenous Immunoglobulin (IVIg) Primary Immunodeficiency Disease (PIDD) Patients Using the CareExchange® System: A Pilot Study Using 5% Gammaplex® IVIg in the Home Setting

NCT02176239 · clinicaltrials.gov ↗
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

BriovaRx Infusion Services

Collaborators